The efficacy of linked color imaging for the endoscopic diagnosis of mucosal healing in quiescent ulcerative colitis

Author(s):  
Tomohisa Takagi ◽  
Kazuhiko Uchiyama ◽  
Mariko Kajiwara‐Kubota ◽  
Saori Kashiwagi ◽  
Yuki Toyokawa ◽  
...  
2019 ◽  
Vol 07 (08) ◽  
pp. E937-E943 ◽  
Author(s):  
Shuji Kanmura ◽  
Hitomi Hamamoto ◽  
Akihito Tanaka ◽  
Shiho Arima ◽  
Fumisato Sasaki ◽  
...  

Abstract Background and aims Recent studies recommend histological mucosal healing of intestinal tissue as a treatment goal in ulcerative colitis (UC). Linked-color imaging (LCI) is a new endoscopy system that enhances the color differences of the gastrointestinal mucosa. We investigated the efficacy of LCI in the evaluation of intestinal activity, including the histological activity in UC. Method A total of 21 UC patients who were evaluated by the LASEREO system (FUJIFILM Co., Tokyo, Japan) were enrolled from August to December in 2016. All of the target points were observed by conventional white-light imaging (WLI) and LCI and biopsied from the region of interest in each view. We quantified the color tones of 73 biopsied points on WLI and LCI using the L*a*b* color value (WLI-L, WLI-a, WLI-b, and LCI-L, LCI-a, LCI-b). We then investigated the relationships among the L*a*b* color values, endoscopic findings, and histological healing. Results The average LCI-a and LCI-b values of patients with high mucosal activity disease were significantly higher than in those with mucosal healing (P < 0.01), and only LCI-a was significantly correlated with the score for histological healing. With regard to the other color values (LCI-L and all WLI values), there were no statistically significant differences in terms of average color value and correlation between patients with high mucosal activity and those with mucosal healing. In addition, the difference in the average color values with LCI and WLI was 7.1 and 3.1, respectively. Conclusion LCI is more useful than WLI for the visualization and evaluation of mucosal inflammation in UC.


2019 ◽  
Vol 114 (1) ◽  
pp. S494-S495
Author(s):  
Hassan Ghoz ◽  
Michael Picco ◽  
Peter Abader ◽  
Murli Krishna ◽  
Bhaumik Brahmbhatt ◽  
...  

2020 ◽  
Vol 55 (9) ◽  
pp. 1114-1120
Author(s):  
Sang Pyo Lee ◽  
Jin Lee ◽  
Sea Hyub Kae ◽  
Hyun Joo Jang ◽  
Dong Hee Koh ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-6
Author(s):  
Shuji Kanmura ◽  
Akihito Tanaka ◽  
Kazuki Yutsudou ◽  
Kosuke Kuwazuru ◽  
Fukiko Komaki ◽  
...  

Ulcerative colitis (UC) is a chronic inflammatory bowel disease with unknown etiology. Recently, mucosal healing has emerged as an important therapeutic endpoint in UC. Linked color imaging (LCI) is a novel endoscopic system that enhances the color differences of the gastrointestinal mucosa. Our previous study emphasized the redness and yellowness of the lesion using LCI observation, which was useful for the evaluation of histological mucosal activity in UC. In this study, we aimed to evaluate the correlation between LCI observation and clinical relapse rate in UC patients. We retrospectively analyzed UC patients who underwent total colonoscopy between August 2016 and October 2018 at our facility with Mayo endoscopic scores of 0 or 1. We assessed the correlation between orange-like color lesion (defined as LCI-scarlet color lesions) and clinical relapse rate (requiring additional treatment for UC) during the 1-year follow-up period. Fifty-eight patients (22 female, 36 male; median age at diagnosis, 47.2 (18–80) years) who underwent colonoscopy were analyzed. During the 1-year follow-up period, clinical relapse was observed in 12 patients (20.1%) among which ten patients (83.3%) had an LCI-scarlet color lesions recognized by LCI. By contrast, 29 patients (63%) had no LCI-scarlet color lesions in the clinical remission group (n=46). There was a significant difference in LCI-scarlet color between the clinical relapse and remission groups, remaining significantly associated with clinical relapse. LCI findings, including an orange-like color lesion, have diagnostic implications for predicting the risk of clinical relapse in UC during the 1-year follow-up period.


2017 ◽  
Vol 152 (5) ◽  
pp. S81-S82
Author(s):  
Daisaku Fujimoto ◽  
Kaizo Kagemoto ◽  
Yasuyuki Okada ◽  
Hironori Tanaka ◽  
Satoshi Teramae ◽  
...  

2016 ◽  
Vol 04 (07) ◽  
pp. E800-E805 ◽  
Author(s):  
Osamu Dohi ◽  
Nobuaki Yagi ◽  
Yuriko Onozawa ◽  
Reiko Kimura-Tsuchiya ◽  
Atsushi Majima ◽  
...  

2017 ◽  
Vol 13 (4) ◽  
pp. 735 ◽  
Author(s):  
Yan Liu ◽  
Xiaotian Sun ◽  
Min Min ◽  
Yiliang Bi ◽  
Yang Xu

Sign in / Sign up

Export Citation Format

Share Document